Meet the team

Diederik Stadig

Portrait of Diederik Stadig

Diederik Stadig

Senior Healthcare Economist

Diederik Stadig is ING's senior healthcare economist. He joined the firm in 2023 and previously worked at de Vrije Universiteit Amsterdam. He holds a PhD in political economy from the same university.  

Globe spot

Diederik is part of the THINK team for TMT and Healthcare.

Latest from Diederik

Where do we stand on pharmaceutical tariffs?
Healthcare Trade
29 July

Where do we stand on pharmaceutical tariffs?

With Trump's latest threat of a 200% tariff on generic medicines, we look at where the pharmaceutical industry stands

Youtube video thumbnail
Video
Healthcare
15 July

A prescription for power – China's biotech boom and the new global…

AI monthly: Many still unconvinced of GenAI’s relevance
TMT AI
27 May

AI monthly: Many still unconvinced of GenAI’s relevance

Nearly two-thirds of EU internet users don’t use GenAI, citing 'no need'. Yet younger, educated heavy users worry most about job loss

China: the next Pfizer will be Chinese
Healthcare China
27 May

China: the next Pfizer will be Chinese

We believe that the next Pfizer will be Chinese

China’s spectacular rise reshapes Asia’s pharma future
Healthcare China
27 May

China’s spectacular rise reshapes Asia’s pharma future

The balance of power in the global pharmaceutical industry is shifting east

South Korea: Asia’s second innovation engine
Healthcare South Korea
27 May

South Korea: Asia’s second innovation engine

India: from generics giant to innovation powerhouse?
Healthcare India
27 May

India: from generics giant to innovation powerhouse?

Japan: Asia's Europe?
Healthcare Japan
27 May

Japan: Asia's Europe?

Meet the team

Meet the team Explore the full team
Makary's successor faces tough task managing FDA amid budget cuts
Commodities, Food & Agri Healthcare United States
18 May

Makary's successor faces tough task managing FDA amid budget cuts

Trump's 100% pharma tariffs will have a limited effect on the sector
Healthcare
3 April

Trump's 100% pharma tariffs will have a limited effect on the sector

Youtube video thumbnail
Healthcare
26 March

Watch: European pharma's fight to stay relevant

Youtube video thumbnail
Video
Healthcare
26 March

European pharma's fight to stay relevant

Webinar: Europe's housing markets in a volatile world
Real estate
25 March

Webinar: Europe's housing markets in a volatile world

Transformative or overhyped? The impact of weight-loss drugs on European food demand
Commodities, Food & Agri Healthcare
20 March

Transformative or overhyped? The impact of weight-loss drugs on European food…

Europe’s last chance to revive its pharmaceutical innovation power
Healthcare
19 March

Europe’s last chance to revive its pharmaceutical innovation power

Pharma’s Godfather moment: pulled back into tariff uncertainty
Healthcare
13 March

Pharma’s Godfather moment: pulled back into tariff uncertainty